Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer
Cancers(2021)
Key words
non-small-cell lung cancer (NSCLC),epidermal growth factor receptor (EGFR),tyrosine kinase inhibitor (TKI),cell division cycle-associated protein 3 (CDCA3),acquired resistance,biomarker
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined